☰

Xiaojing Shi - Publications

Affiliations: 
University of Southern California, Los Angeles, CA, United States 
Tree Info Similar researchers PubMed Report error

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Cai M, Xu S, Jin Y, Yu J, Dai S, Shi XJ, Guo R. hMOF induces cisplatin resistance of ovarian cancer by regulating the stability and expression of MDM2. Cell Death Discovery. 9: 179. PMID 37291112 DOI: 10.1038/s41420-023-01478-y  0.308
2022 Asmamaw MD, Shi XJ, Zhang LR, Liu HM. A comprehensive review of SHP2 and its role in cancer. Cellular Oncology (Dordrecht). 45: 729-753. PMID 36066752 DOI: 10.1007/s13402-022-00698-1  0.357
2021 Cheng Q, Dai Z, Shi X, Duan X, Wang Y, Hou T, Zhang Y. Expanding the toolbox of exosome-based modulators of cell functions. Biomaterials. 277: 121129. PMID 34534861 DOI: 10.1016/j.biomaterials.2021.121129  0.661
2020 Shi X, Zhang XN, Chen J, Cheng Q, Pei H, Louie SG, Zhang Y. A poly-ADP-ribose polymer-based antibody-drug conjugate. Chemical Science. 11: 9303-9308. PMID 33623656 DOI: 10.1039/D0Sc01795G  0.651
2020 Shi X, Zhang Y. A Humanized Antibody Inhibitor for Cathepsin L. Protein Science : a Publication of the Protein Society. PMID 32683733 DOI: 10.1002/pro.3913  0.343
2020 Cheng Q, Shi X, Zhang Y. Reprogramming Exosomes for Immunotherapy. Methods in Molecular Biology (Clifton, N.J.). 2097: 197-209. PMID 31776927 DOI: 10.1007/978-1-0716-0203-4_12  0.695
2019 Shi X, Cheng Q, Hou T, Han M, Smbatyan G, Lang JE, Epstein AL, Lenz HJ, Zhang Y. Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31843452 DOI: 10.1016/J.Ymthe.2019.11.020  0.685
2019 Shi X, Cheng Q, Zhang Y. Reprogramming Extracellular Vesicles with Engineered Proteins. Methods (San Diego, Calif.). PMID 31568822 DOI: 10.1016/J.Ymeth.2019.09.017  0.597
2018 Cheng Q, Shi X, Han M, Smbatyan G, Lenz HJ, Zhang Y. Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity. Journal of the American Chemical Society. PMID 30452238 DOI: 10.1021/Jacs.8B10047  0.69
2018 Lv Y, Song Y, Ni C, Wang S, Chen Z, Shi X, Jiang Q, Cao C, Zuo Y. Overexpression of Lymphocyte Antigen 6 Complex, Locus E in Gastric Cancer Promotes Cancer Cell Growth and Metastasis. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 45: 1219-1229. PMID 29448250 DOI: 10.1159/000487453  0.304
2016 Shi XJ, Yu B, Wang JW, Qi PP, Tang K, Huang X, Liu HM. Structurally novel steroidal spirooxindole by241 potently inhibits tumor growth mainly through ROS-mediated mechanisms. Scientific Reports. 6: 31607. PMID 27527552 DOI: 10.1038/srep31607  0.342
2016 Zhang X, Ling Y, Guo Y, Bai Y, Shi X, Gong F, Tan P, Zhang Y, Wei C, He X, Ramirez A, Liu X, Cao C, Zhong H, Xu Q, et al. Mps1 kinase regulates tumor cell viability via its novel role in mitochondria. Cell Death & Disease. 7: e2292. PMID 27383047 DOI: 10.1038/Cddis.2016.193  0.301
2016 Xie S, Qin J, Liu S, Zhang Y, Wang J, Shi X, Li D, Zhou J, Liu M. Cep70 overexpression stimulates pancreatic cancer by inducing centrosome abnormality and microtubule disorganization. Scientific Reports. 6: 21263. PMID 26893288 DOI: 10.1038/srep21263  0.31
Show low-probability matches.